Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jun 19;22(1):23.
doi: 10.1186/s12979-025-00516-w.

Frequency of synaptic antigen-specific CD4+ T cells in dementia is age-dependent but not correlated with cognitive impairment

Affiliations

Frequency of synaptic antigen-specific CD4+ T cells in dementia is age-dependent but not correlated with cognitive impairment

Julius Hoffmann et al. Immun Ageing. .

Abstract

Neurodegenerative dementias including Alzheimer disease severely impair cognitive and social abilities and are a major cause of mortality with no causal treatment yet. Autoimmune mechanisms have been increasingly considered to contribute to disease progression, e.g. by enhancing protein misfolding or pro-inflammatory immune responses. Understanding this contribution may lead to novel treatment options beyond removing neurodegeneration-associated proteins. We hypothesized that CD4+ TH cells against synaptic proteins may play a role in dementia, given the profound changes of synaptic proteins in the disease. We investigated TH cell frequencies and phenotypes after antigen-reactive T cell enrichment (ARTE) using three important synaptic antigens known to play a role in cognitive function, N-Methyl-D-Aspartate receptor (NMDAR), Leucine-rich, glioma inactivated 1 (LGI1) and metabotropic glutamate receptor 5 (mGluR5). Our data revealed that synaptic autoantigen-specific TH cells occurred in all cohorts and were similarly frequent in patients with dementia and sex- and age-matched controls. However, they were significantly reduced compared to young healthy subjects, indicating strong age-related effects ('immune senescence'). Compared to the ubiquitously available Candida albicans antigen, synaptic autoantigen-specific TH cell responses were strongly driven by IFNγ-producing T cells, expression of which markedly decreased with age. Patients with dementia had significantly less IL-17-producing synaptic autoantigen-specific TH cells than aged healthy controls. This first direct ex vivo quantitative and qualitative analysis of circulating T cells autoreactive to three synaptic autoantigens in dementia shows no correlation with cognitive impairment. It suggests that synaptic autoantigen-specific TH cells decline with age and are not a major driver of dementia development.

Keywords: Dementia; Immune senescence; LGI1; MGluR5; NMDA receptor; Synaptic autoantigens; T cells.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethics approval and consent to participate: All clinical studies adhered to the guidelines of the Declaration of Helsinki. Participants at the memory outpatient clinic of the Department of Neurology, Charité – Universitätsmedizin Berlin, provided written informed consent before joining the study. The Charité Institutional Review Board approved all conducted analyses (EA1/129/14). Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Normal CD4+ TH cell frequencies in dementia patients and healthy controls. A Flow cytometry gating strategy used in this project. Lymphocytes were selected from PBMCs, gated for live CD4+ TH cells and then for CD154+ TH cells followed by differentiation of memory and naïve T cell subsets. B Without antigen stimulation, PBMCs showed similar frequencies of CD4+ TH cells in all cohorts. C Naïve T cells and memory T cells (including memory T subsets) did not differ between all three cohorts in unstimulated condition
Fig. 2
Fig. 2
CD154+ TH cells targeting neuronal antigens decrease with age. A Frequencies of CD154+ TH cells after stimulation with the respective antigen (Candida, NR1, LGI1, mGluR5) were similar in dementia patients and aged controls, but markedly lower compared to young controls. B No differences between CD154+ TH cell frequencies after stimulation with neuronal surface antigens among different dementia subgroups. C Significant age-dependent decrease of neuronal antigen-specific CD154+ TH cells. The reduction was particularly obvious in the aged group, where no decrease was observed following stimulation with Candida albicans (right). D Regression analyses illustrating the relationship between CD154+ TH cell frequencies and MMSE score, displaying a significant decrease of neuronal antigen-specific, but not Candida-specific CD154+ TH cells in patients with reduced MMSE scores. E In regression analyses between MMSE scores and age, MMSE scores did not significantly correlate with age
Fig. 3
Fig. 3
Tmemory cells were most strongly linked to the age-dependent reduction in TH cell frequency after synaptic antigen stimulation. A Naïve TH cells against synaptic antigens were equally frequent in all cohorts, in contrast to increased frequencies in the Candida-stimulated group of young controls. B Memory TH cells were significantly more frequent in young controls in both, the Candida-stimulated and synaptic antigen-stimulated groups. C-E Within the memory compartment, TEM were more frequent than TCM and TEMRA cells. Within those subsets, no differences were found between cohorts after stimulation with neuronal antigens
Fig. 4
Fig. 4
Differential cytokine profiles in CD154+ TH cells. A TNFα was the main inflammatory cytokine in Candida-specific TH cells. Lower frequencies were observed in TH cells after stimulation with neuronal antigens. B IFNγ production predominated in synaptic antigen-specific CD4+ TH cells, in particular in young healthy controls with nearly twice as much IFNγ production compared to aged controls and dementia patients. C IL-17 production after stimulation with synaptic antigens was significantly increased in healthy aged subjects compared to dementia patients and young controls

Similar articles

References

    1. Collaborators GBDDF. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 2022;7(2):e105-e25. 10.1016/S2468-2667(21)00249-8 [published Online First: 2022/01/10] - PMC - PubMed
    1. Alzheimer’s disease facts and figures. Alzheimers Dement. 2021;17(3):327–406. 10.1002/alz.12328. [publishedOnlineFirst:2021/03/24] - PubMed
    1. Taylor JP, McKeith IG, Burn DJ, et al. New evidence on the management of Lewy body dementia. Lancet Neurol. 2020;19(2):157–69. 10.1016/S1474-4422(19)30153-X. [publishedOnlineFirst:2019/09/15] - PMC - PubMed
    1. Sims JR, Zimmer JA, Evans CD, et al. Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330(6):512–27. 10.1001/jama.2023.13239. [publishedOnlineFirst:2023/07/17] - PMC - PubMed
    1. van Dyck CH, Swanson CJ, Aisen P, et al. Lecanemab in Early Alzheimer’s Disease. N Engl J Med. 2023;388(1):9–21. 10.1056/NEJMoa2212948. [publishedOnlineFirst:2022/12/01] - PubMed

LinkOut - more resources